Cilostazol.
D000818:Animals; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D002319:Cardiovascular System / Q000187:drug effects / Q000378:metabolism; D000077407:Cilostazol; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004347:Drug Interactions; D004348:Drug Labeling / Q000706:statistics & numerical data; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy* / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D013777:Tetrazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics
D001993:Bronchodilator Agents; D010726:Phosphodiesterase Inhibitors; D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol